tuberculosis
Qiagen Sues BioMérieux in German Court for Infringing Tuberculosis Test Patent
Qiagen alleges that BioMérieux infringes a European patent that protects the company's QuantiFeron interferon-gamma release assay technology for latent TB detection.
German Patent Court Upholds Qiagen Patent Suit Against SD Biosensor
Qiagen said the intellectual property in question covers technologies used in its QuantiFeron latent tuberculosis assays.
Gates Foundation Awards Detact Diagnostics $5.9M for POC Test, System Development
The Dutch firm will develop assays for syphilis and tuberculosis using its infrared light-based protein detection technology.
Cepheid Tuberculosis Assay Receives WHO Prequalification
The WHO noted that Cepheid's test is the first test for tuberculosis and antibiotic susceptibility testing that meets the prequalification standards.
Top Five Articles on 360Dx Last Week: Lab Priorities During Elections; Cepheid TB Test Pricing; More
Last week, readers were most interested in a story about how priorities for the lab industry could play out depending on election results.
Aug 5, 2024
May 23, 2024
Apr 8, 2024
Apr 27, 2023